In the evening of June 19th, 2020, sponsored by Beijing Honglin pharmaceutical company, the On-Line Academic Seminars for Hypertension in Rural Communities of China was held. Participants of this academic event included PHD of Europe & Asia Science faculty of China Research Institute, Deputy Chief Editor of China Hypertension Disease Magazine, Professor Sun Yingxian, Deputy Chief Director and member of the Committee of Hypertension Disease of Chinese Medical Doctor Association (CMDA ) and the Vice president of Cardiology Division of China Medical University 1st Hospital Chang ZeXin, President of Cardiology Department of the Hospital of People in DongGuan, Dr. Guo SuXia. The seminar was presided by Professor Sun.
Direction of Hypertension Treatment in Rural Communities of China.
According to the 5 nationwide polls implemented during the periods of year 1958 to 1959, year 1979 to 1980, year 1991, year 2002, and year 2012 to 2015, case rate of hypertension is on the rise, the number of total patients with hypertension reaches 245 million.
“Success Stories”domestic&foreign, indicate that the most effective methodology against hypertension is “Community Containment”. Doctors and therapists in base-level hospitals are by means the main forces to fight hypertension cases in local communities, local medication and sanitary institutes carry the responsibilities of diagnosis, treatment and follow-ups in long term of local hypertension cases. They directly decide the overall national performance against hypertension.
The “On-Line Academic Seminars for Hypertension in Rural Communities of China”, organized by Beijing Honglin pharmaceutical company aims at interacting and founding with every medical team to create an “Managerial Solution” that consequently lead to a “Cloud Platform” which shares information and experiences to fight hypertension.
01 Analysis of Solutions for hypertension in local communities
Along with the tendency of rejuvenation of hypertension and the increase of case rates and death rate of cardiovascular diseases, in order to reduce the number of new cases, and to detect the potential patients, instead of sitting in the clinic or the hospital, doctors should “Get out and Go local” to visit local communities , implement “hypertension-fighting” protocols to improve the situation.
During the seminar, President of Cardiology Department of the Hospital of People in DongGuan, Dr. Guo SuXia shares her insightful ideas about the latest-released “Directions against hypertension for Local Communities”, covering from the basis from etiology, pathology, diagnosis, risks-allocations, referral, to treatment. She also gave concise remarks on the experiences of treatment of urgent and sub-urgent hypertension cases shared by the local medical institutes.
02 A close look of the application of CCB (calcium channel blocker) in the point of view of “treatment guideline against Hypertension”
Following Guo Suxia’s speech, Deputy Chief Director and member of the Committee of Hypertension Disease of Chinese Medical Doctor Association ( CMDA ) and the Vice president of Cardiology Division of China Medical University 1st Hospital Chang ZeXin gave a comment about the reasonable usage of CCB according to “treatment guideline against hypertension“, which mentioned the combined-usage of CCB drugs and the important performance of CCB in the treatment of Hypertension diseases. In the meanwhile, he also said that in comparison to CCB drugs which have short term of effectiveness, Nefidipine can remarkably reduce the chances of CAD.
03 Q & A time –
Speeches of the 2 professors received high remarks from the crowds, active comments and suggestions were given by different doctors online and formulated a new direction for the war against HCVD (hypertensive cardiovascular disease), 3 profs gave detailed answers according to their self-experiences to the questions given by participants.
In the end of the on line seminar, Professor Sun Yingxian gave a closing speech and pulled down certain of this fabulous event.
2021 官网升级中!现在您访问官网的浏览器设备分辨率宽度低于1280px请使用高分辨率宽度访问。